TCTMD

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Initial data looking at safety and efficacy of an interatrial septal occluder with a bioresorbable frame show promise for closing atrial septal defects (ASDs), but the study authors suggest a redesign ...
Medscape

Transcatheter PFO and ASD closure safe and effective, aided by intracardiac ultrasound guidance

Rochester, MN - A new case series of patients with a previous stroke suggests that transcatheter device closure of patent foramen ovale (PFO) and atrial septal defect (ASD) is safe and eliminated ...
Science Daily

Device achieves 90 percent closure rate for atrial septal defect in children; Biodegradable implant avoids risks associated with metal devices

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...
Medscape

FDA OKs ASD Device for PFO Closure to Prevent Recurrent Stroke

The US Food and Drug Administration (FDA) has approved the Gore Cardioform septal occluder for closure of patent foramen ovale (PFO) to prevent recurrent ischemic stroke, the manufacturer, WL Gore & ...
TCTMD

Transcatheter Device Matches Surgery for Closure of Ventricular Septal Defects

In children with perimembranous ventricular septal defects (VSDs), closure with a catheter-delivered occluder device is safe, providing midterm outcomes similar to those of open-heart surgery, ...